Protect Our Care WI: Biden Administration announces plans to utilize march-in rights to lower drug prices for patients
Washington, D.C. — Today, the Biden administration announced plans to lower prices for certain high-priced medicines that were developed with taxpayer dollars by creating a policy for using federal “march-in rights” to license other manufacturers sell those drugs for less.